Drugs / Umbilical-cord mesenchymal stromal cells
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03166865 | Oct 2018 → Jun 2020 | osteoarthritis, knee | Liaocheng People's Hospital | Unknown | No outcome recorded |
| Phase 1/2 | NCT02580695 | Dec 2015 → Jan 2017 | osteoarthritis, knee | Francisco Espinoza, MD | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | umbilical-cord mesenchymal stromal cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02580695 ↗ |
| Known as | UC-MSCs | “Umbilical-cord mesenchymal stromal cells (UC-MSCs)” NCT03166865 ↗ |
| Modality | Cell therapy | “Umbilical-cord mesenchymal stromal cells (UC-MSCs)” NCT03166865 ↗ |
| Route | Other | “Intra-articular knee injection of UC-MSC 20x10e6 at 0 and 6 months” NCT02580695 ↗ |